AERI
Aerie Pharmaceuticals
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
137 hedge funds and large institutions have $522M invested in Aerie Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 52 increasing their positions, 38 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
28% less capital invested
Capital invested by funds: $727M → $522M (-$205M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
137
Holding in Top 10
–
Calls
$3.27M
Puts
$1.06M
Top Buyers
| 1 | +$24.5M | |
| 2 | +$7.87M | |
| 3 | +$6.78M | |
| 4 |
Morgan Stanley
New York
|
+$4.05M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$3M |
Top Sellers
| 1 | -$30M | |
| 2 | -$6.71M | |
| 3 | -$6.7M | |
| 4 |
ACM
Atika Capital Management
New York
|
-$6.33M |
| 5 |
Two Sigma Investments
New York
|
-$2.9M |